Acumen Pharmaceuticals, Inc. (ABOS) (CIK 0001576885) CORRESP
A CORRESP letter is the company's written reply to the SEC during a filing review. Responses include accounting position arguments, restatement assessments, and clarifying disclosures. Released to EDGAR alongside the SEC's UPLOAD letters.
Key facts
- Accession number
- 0001628280-26-022032
- Form
- CORRESP
- Filer
- Acumen Pharmaceuticals, Inc. (ABOS) (CIK 0001576885)
- CIK
- 0001576885
- Ticker
- ABOS
- Filed
- 2026-03-30
- SIC industry
- 2836
- HQ
- Newton, MA
Primary source
PDF letter: https://www.sec.gov/Archives/edgar/data/1576885/000162828026022032/filename1.htm
EDGAR review index: browse all UPLOAD/CORRESP for this filer ↗
Other comment-letter activity for this filer